Knowledge of the cell-type specific make-up of the brain is useful to understand the role of each cell type as part of the network, is necessary...
Planetarians' plant-based whole cuts of protein have a umami-like flavor and are made with two ingredients: the oil cakes and brewer's yeast. Planetarians...
The groundbreaking study led by Heroic Hearts Project will follow 40 vets through a week of group healing activities at a Jamaican psilocybin retreat center,...
Psychedelic business is a term that was only whispered on the fringes of society not too long ago. But, today they are popping up all over...
The article Small Pharma Doses First Patient in DMT Phase I Trial was originally published on Microdose. Small Pharma has begun dosing for its trial of...
The article Decrim Update: Arizona Unanimously Approves Psilocybin Research Bill was originally published on Microdose. Arizona, a historically conservative...
FT. LAUDERDALE, FL /February 14, 2023 / Kaya Holdings, Inc., (“KAYS” or the “Company”) (OTCQB: KAYS), a pioneer in the U.S. cannabis industry,...
Early research indicates that psychedelics may play a key role in this arena. The post Can Psychedelics Combat Aging in Humans? appeared first on Green...
Leading Direct Marketing Automation Company Celebrates 2022 with Key Growth, Global Expansion, Innovation, and Customer Experience Milestones; Achieves...
A new research project aims to destigmatize long lasting negative psychedelic experiences and investigate support methods. The post Exploring the Challenges...
Filament Health Corp. (OTCQB: FLHLF | NEO: FH | FSE: 7QS), a clinical–stage natural psychedelic drug development company, today announced a second agreement...
The article Cybin Reports Q3 Financial Results and Business Highlights was originally published on Microdose. Cybin has released its Q3 financial results...
The article Valentine’s Day Perspective: Sex and Psychedelics was originally published on Microdose. To help celebrate Valentine’s Day, we’re re-posting...
The company received approval in the Netherlands to start dosing humans with one of its compounds. The post Cybin Maintains Steady Runway, Finds Approval...
Reunion Neuroscience Inc. (NASDAQ: REUN) reported financial results for the third quarter ending December 31, 2022 with no revenue for the biotech company....